Bringing the fundamentals into focus…
Back to Halozyme Therapeutics, Inc.
How Halozyme Therapeutics, Inc. stacks up
HALO · against 454 other Healthcare companies listed in US-listed
Growth
80/ 100
Above the middle of the pack.
Ranked #145 of 455 · scores higher than 67% of peers
Bars: peers in each 10-point band of the growth score66 peers with a growth score of 80–89, including HALO · Click a bar to see the companies
Why growth scores 80?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- slower growth in earnings per share: weaker than 78% of peers. Earnings per share growth: -23.5% vs peer median 9.8%
- faster revenue growth over three years: stronger than 87% of peers. 3-year revenue growth: 29.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 89% of peers. Revenue growth: 41.2% vs peer median 6.1%
Metric by metric
Position: dot = HALO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | HALO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 41.2% | 11.0% | 80% | 33% | |
| Earnings per share growthHigher is better · 171 reported | -23.5% | 21.2% | 18% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 29.1% | 11.0% | 77% | 33% |
Ranking by growth score
Top 5 and the companies ranked around HALO| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 138 | 1.1B USD | 81 | 50 | |
| 145 | 3.5B USD | 80 | 75 | |
| 145 | 1.2B USD | 80 | 67 | |
| 145 | Unavailable | 80 | 56 | |
| 145 | 14.6B USD | 80 | 59 | |
| 145 | 14.9B USD | 80 | 65 | |
| 145 | 9.0B USD | 80 | 78 | |
| 145 | 10.1B USD | 80 | 61 | |
| 152 | 449M USD | 79 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score